Immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging infectious diseases including covid-19 (SARS-C0V2)
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,494,557
Award facts
- Opportunity
-
- Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases Pre-Solicitation · Posted Feb 6, 2017
- Contract value 28% obligated
-
- $3,494,557.00 Current, with exercised options
- $12,290,377.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,064,710 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,429,847 |
About this award
This is a delivery order contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging infectious diseases including COVID-19 (SARS-CoV-2). The total ceiling value of the contract is $12,290,377.00. The contract is a cost-plus-fixed-fee type with an ultimate completion date of April 30, 2024. This award is not a set-aside contract. Battelle has engaged two subcontractors, Life Technologies Corporation and Bio-Rad Laboratories, Inc., to provide specialized laboratory instrumentation, reagents, and services in support of the testing efforts under this contract. The NIAID frequently partners with organizations like Battelle to conduct biomedical research and testing to support the development of medical countermeasures for emerging infectious disease threats.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 21, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $3,494,557 on 75N93020F00003. Its potential value, with all options, is $12,290,377.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under 75N93018D00013, an indefinite delivery contract.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award